Compounds > mci 9038
Page last updated: 2024-08-26

mci 9038 and Shock, Cardiogenic

mci 9038 has been researched along with Shock, Cardiogenic in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Curtis, BR; Erdil, RM; Gilyard, SN; Knelson, EH; Leaf, RK; Malhotra, R; Puram, RV; Ranganathan, R; Van Beuningen, AM; Wallwork, R; Weber, BN1
Laliberte, B; Reed, BN1
Aissaoui, N; Ajzenberg, N; Amour, J; Besnier, E; Borie, M; Bougon, D; Chardonnal, L; Delmas, C; Dessertaine, G; Girerd, N; Grisot, PH; Guidon, C; Helms, J; Kimmoun, A; Labro, G; Lamiral, Z; Levy, B; Medard, A; Megarbane, B; Mongardon, N; Nesseler, N; Ouattara, A; Oulehri, W; Pierrot, M; Renou, A; Rozec, B; Schmidt, M; Sonneville, R; Zogheib, E1
Donahue, KR; Succar, L; Sulaica, EM; Wanat, MA1
Böhm, M; Link, A; Pöss, J1

Reviews

1 review(s) available for mci 9038 and Shock, Cardiogenic

ArticleYear
Management of Anticoagulation with Impella® Percutaneous Ventricular Assist Devices and Review of New Literature.
    Journal of thrombosis and thrombolysis, 2019, Volume: 48, Issue:2

    Topics: Anticoagulants; Arginine; Heart-Assist Devices; Humans; Pipecolic Acids; Shock, Cardiogenic; Sulfonamides

2019

Other Studies

4 other study(ies) available for mci 9038 and Shock, Cardiogenic

ArticleYear
Thrombocytopenia and Thromboses in Myocardial Infarction Associated with Eptifibatide-Dependent Activating Antiplatelet Antibodies.
    Thrombosis and haemostasis, 2020, Volume: 120, Issue:7

    Topics: Antigens, Human Platelet; Arginine; Aspirin; Autoantibodies; Combined Modality Therapy; Coronary Thrombosis; Drug Substitution; Drug Therapy, Combination; Eptifibatide; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Platelet Transfusion; Purpura, Thrombocytopenic, Idiopathic; Shock, Cardiogenic; ST Elevation Myocardial Infarction; Stents; Sulfonamides; Thrombectomy; Thrombolytic Therapy; Thrombosis; Ticagrelor; Warfarin

2020
Use of an argatroban-based purge solution in a percutaneous ventricular assist device.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2017, May-01, Volume: 74, Issue:9

    Topics: Aged; Anticoagulants; Arginine; Blood Coagulation; Drug Substitution; Female; Heart-Assist Devices; Heparin; Humans; Pipecolic Acids; Shock, Cardiogenic; Sulfonamides; Takotsubo Cardiomyopathy; Thrombocytopenia; Treatment Outcome

2017
Prevalence and outcome of heparin-induced thrombocytopenia diagnosed under veno-arterial extracorporeal membrane oxygenation: a retrospective nationwide study.
    Intensive care medicine, 2018, Volume: 44, Issue:9

    Topics: Adult; Aged; Anticoagulants; Arginine; Critical Care; Diagnosis, Differential; Extracorporeal Membrane Oxygenation; Female; France; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Aggregation Inhibitors; Platelet Count; Prevalence; Retrospective Studies; Shock, Cardiogenic; Sulfonamides; Thrombocytopenia; Treatment Outcome

2018
[Diagnosis and treatment of heparin-induced thrombocytopenia].
    Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:18

    Topics: Acute Kidney Injury; Aged; Anticoagulants; Antithrombins; Aortic Valve Stenosis; Arginine; Diagnosis, Differential; Hand; Heparin; Humans; Ischemia; Male; Pipecolic Acids; Platelet Count; Renal Dialysis; Shock, Cardiogenic; Sulfonamides; Thrombocytopenia; Ventricular Dysfunction, Left

2011